Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Revenue

Harmony Biosciences Holdings had revenue of $186.04M in the quarter ending September 30, 2024, with 16.08% growth. This brings the company's revenue in the last twelve months to $681.88M, up 25.83% year-over-year. In the year 2023, Harmony Biosciences Holdings had annual revenue of $582.02M with 32.93% growth.

• Revenue (ttm): $681.88M
• Revenue Growth: +25.83%
• P/S Ratio: 3.25
• Revenue / Employee: $2,771,866
• Employees: 246
• Market Cap: 2.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	582.02M	144.17M	32.93%
Dec 31, 2022	437.86M	132.42M	43.35%
Dec 31, 2021	305.44M	145.70M	91.21%
Dec 31, 2020	159.74M	153.75M	2,564.59%
Dec 31, 2019	6.00M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.